The authors speculated that it may be after a relapse of B-ALL, the up-regulation of three metabolic genes of NADSYN1, PARP6 and SIRT3, was promoted in response to certain tumor factors. The gene discussed is NADSYN1; the disease is acute lymphoblastic leukemia.